Published in Am J Epidemiol on January 01, 1982
Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev (2000) 2.45
Laboratory-associated infections and biosafety. Clin Microbiol Rev (1995) 2.30
Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health (2001) 1.67
Uptake of immunisation against hepatitis B among surgeons in Wessex Regional Health Authority. BMJ (1990) 1.51
Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol (1984) 1.43
Acceptance of hepatitis B vaccine among hospital workers. Am J Public Health (1986) 1.39
Glue ear: the new dyslexia? Br Med J (Clin Res Ed) (1985) 1.18
The importance of implementing safe sharps practices in the laboratory setting in Europe. Biochem Med (Zagreb) (2014) 0.98
Hepatitis among hospital employees. West J Med (1983) 0.94
Cost without benefit? The introduction of hepatitis B vaccine in Canada. Can Med Assoc J (1983) 0.89
Epidemiology of viral hepatitis among US Navy and Marine Corps personnel, 1984-85. Am J Public Health (1987) 0.84
Potential for laboratory exposures to biohazardous agents found in blood. Am J Public Health (1990) 0.84
Bloodborne pathogens exposure from occupational fingernail scratches. J Natl Med Assoc (2007) 0.83
Preventing hepatitis B in health care workers. Can Fam Physician (1985) 0.81
Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine. Am J Public Health (1990) 0.80
Prevalence and factors associated with hepatitis B immunization and infection among men who have sex with men in Beijing, China. PLoS One (2012) 0.79
An occupational health services initiative at a women's hospital in Kabul, Afghanistan. Public Health Rep (2007) 0.79
Prevalence of hepatitis B markers among district general hospital staff. Br Med J (Clin Res Ed) (1985) 0.78
Occupational exposure to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) among embalmers: a pilot seroprevalence study. Am J Public Health (1989) 0.77
Bacteriological evaluation of a down-draught necropsy table ventilation system. J Clin Pathol (1993) 0.76
Occupational and non-occupational hepatitis B virus infection among hospital employees in Jerusalem: a basis for immunisation strategy. Br J Ind Med (1992) 0.75
Human immunodeficiency virus infections: considerations for health care workers. Bull N Y Acad Med (1988) 0.75
Prevalence of hepatitis B serologic markers in community hospital personnel. Am J Public Health (1987) 0.75
Risk of hepatitis B infection among medical and paramedical workers in a general hospital in Zimbabwe. J Clin Pathol (1988) 0.75
Exposure to hepatitis B: review of current concepts. Bull N Y Acad Med (1989) 0.75
Hepatitis B vaccine requirements in at-risk hospital personnel: a survey of hospitals in Metropolitan Toronto. Can Med Assoc J (1983) 0.75
Nosocomial transmission of bloodborne viruses from infected health care workers to patients. Can J Infect Dis (2003) 0.75
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Cefuroxime - a new cephalosporin antibiotic. J Antibiot (Tokyo) (1976) 7.95
GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother (1980) 6.77
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med (1989) 4.69
Cefuroxime, a new cephalosporin antibiotic: activity in vivo. Antimicrob Agents Chemother (1976) 4.61
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med (1990) 4.53
Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci (1999) 3.77
Laoratory appraisal of cephalexin. Antimicrob Agents Chemother (Bethesda) (1968) 3.75
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53
4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob Agents Chemother (1993) 2.92
Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 2.77
Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med (1982) 2.58
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology (1983) 2.56
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology (2001) 2.30
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination. Infect Immun (1976) 2.27
Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis (1978) 2.21
Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology (1993) 2.20
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
Distribution of antibody to hepatitis a antigen in urban adult populations. N Engl J Med (1976) 1.81
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood (1990) 1.64
Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med (1977) 1.63
Inhibition of beta-lactamase decomposition of cephaloridine and cephalothin by other cephalosporins. Antimicrob Agents Chemother (Bethesda) (1966) 1.61
Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology (1985) 1.60
Foodhandler-associated outbreak of hepatitis type A. An immune electron microscopic study. Ann Intern Med (1975) 1.58
Faecal shedding of hepatitis-A antigen. Lancet (1975) 1.54
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis (1986) 1.51
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis (1976) 1.51
Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol (1988) 1.49
non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention. Gastroenterology (1983) 1.48
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol (2001) 1.38
Mussel-associated viral hepatitis, type A: serological confirmation. Lancet (1976) 1.36
Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity? Scand J Infect Dis (1980) 1.31
A morphological study of experimental rabbit staphylococcal endocarditis and aortitis. I. Formation and effect of infected and uninfected vegetations on the aorta. Br J Exp Pathol (1986) 1.30
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid. Antimicrob Agents Chemother (1982) 1.28
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis (1986) 1.27
Halothans hepatitis: allergy or idiosyncrasy? N Engl J Med (1980) 1.26
Quantitation of antibody to hepatitis A antigen by immune electron microscopy. Infect Immun (1976) 1.24
Relapsing viral hepatitis type A. J Med Virol (1985) 1.22
The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg (1992) 1.22
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther (1994) 1.20
Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae. Antimicrob Agents Chemother (1977) 1.19
Alterations of T-cell subsets in primary biliary cirrhosis. Clin Exp Immunol (1982) 1.16
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis (1999) 1.16
Detection of cytomegalovirus antibody by immune adherence hemagglutination. Proc Soc Exp Biol Med (1976) 1.15
Interpretation of various serological profiles of hepatitis B virus infection. Am J Clin Pathol (1981) 1.15
ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol Cell Neurosci (2000) 1.14
Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes. J Immunol (1980) 1.14
Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak. JAMA (1981) 1.13
The pathology of viral hepatitis types A and B in chimpanzees. A comparison. Am J Pathol (1976) 1.13
A problem in the interpretation of beta-lactam antibiotic levels in tissues. J Antimicrob Chemother (1983) 1.12
Urticaria associated with acute viral hepatitis type B: studies of pathogenesis. Ann Intern Med (1978) 1.11
Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest (1994) 1.09
An outbreak of type A viral hepatitis at the Naval Training Center, San Diego: epidemiologic evaluation. Am J Epidemiol (1977) 1.08
Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology (1996) 1.08
Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector. Proc Natl Acad Sci U S A (1986) 1.07
Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin. J Antimicrob Chemother (1985) 1.07
A morphological study of experimental staphylococcal endocarditis and aortitis. II. Inter-relationship of bacteria, vegetation and cardiovasculature in established infections. Br J Exp Pathol (1986) 1.06
Aplastic anemia and non-A, non-B hepatitis. Am J Med (1983) 1.06
Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus. J Med Virol (1999) 1.04
Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol (1985) 1.04
Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs. J Immunol (1976) 1.03
Circulating immune complexes in non-A, non-B hepatitis. Possible masking of viral antigen. Lancet (1979) 1.01
Implanted cotton threads; a novel method for measuring concentrations of antibiotics in tissue fluid. J Antimicrob Chemother (1979) 1.01
Antibody to hepatitis A antigen in institutionalized mentally retarded patients. JAMA (1977) 1.01
Comparative pharmacokinetics of ceftazidime in fibrin clots and cardiac vegetations in rabbits with Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1985) 1.01
Transfusion-associated non-A, non-B hepatitis. Where do we go from here? Gastroenterology (1988) 1.00
The natural history of chronic hepatitis C and what we should do about it. Gastroenterology (1997) 1.00
Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation (1998) 0.99
Influence of surface area/volume ratio on the kinetics of antibiotics in different tissues and tissue fluids. Scand J Infect Dis Suppl (1985) 0.99
The pathology of viral hepatitis in chimpanzees. Virchows Arch A Pathol Anat Histol (1980) 0.99
Etiological spectrum of post-transfusion hepatitis. Gastroenterology (1975) 0.99
Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med (1980) 0.98
Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat (2007) 0.97
Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med (1987) 0.97
Serologic comparison of hepatitis A antigen to echovirus 25 isolate CR69(076) recovered from a patient with viral hepatitis. Intervirology (1977) 0.97
Therapeutic activity of ceftazidime and eleven other beta-lactam antibiotics against experimental Haemophilus influenzae, type b meningitis. J Antimicrob Chemother (1984) 0.96
Experimental staphylococcal endocarditis and aortitis. Morphology of the initial colonization. Virchows Arch A Pathol Anat Histopathol (1986) 0.96
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. J Viral Hepat (2008) 0.95
Non-A, non-B post-transfusion hepatitis. Lancet (1977) 0.94
Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen. Ann Intern Med (1982) 0.94
Letter: Immune electron microscopy and hepatitis A. Lancet (1975) 0.93
Cryoprotein complexes and peripheral neuropathy in a patient with chronic active hepatitis. Gastroenterology (1976) 0.92
Cure of hemophilia A by orthotopic liver transplantation. Gastroenterology (1988) 0.92
In vitro studies of enhanced IgG synthesis in severe alcoholic liver disease. Clin Exp Immunol (1981) 0.91
Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection. JAMA (1976) 0.90
Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits. J Antimicrob Chemother (1984) 0.90
Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness. Am J Med Sci (1980) 0.90
Liver-specific protein: more questions than answers. N Engl J Med (1978) 0.90
Hepatitis type A and hemodialysis: a seroepidemiologic study in 15 U.S. centers. Ann Intern Med (1977) 0.89
Antibody to hepatitis A and B in children in New York City. Pediatrics (1978) 0.89
Comparison of serological tests for antibody to hepatitis A antigen, using coded specimens from individuals infected with the MS-1 strain of hepatitis A virus. Infect Immun (1976) 0.89
Hepatitis A virus: virologic, clinical, and epidemiologic studies. Hum Pathol (1981) 0.89
Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group. J Viral Hepat (1994) 0.88
Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr (1985) 0.88